LARGO, Fla., June 27 /PRNewswire-FirstCall/ -- The Advanced Wound Management division of Smith & Nephew plc (LSE:SNLSE:NYSE:LSE:SNN), the global medical technology business, announced today its plans to move the operations of its negative pressure wound therapy (NPWT) business from California to its US headquarters in Largo, Florida. There will be a phased withdrawal from the facility in California which is expected to close in about six month's time. The move to Florida is planned as part of the integration of BlueSky Medical Group Inc which was acquired in May this year. BlueSky's products are part of Smith & Nephew's range of customer solutions for hard-to-heal wounds and are the cornerstone for the development of Smith & Nephew's global NPWT business. Joe Woody, President of Advanced Wound Management said, "We are very excited about BlueSky's products and the opportunities in the negative pressure wound therapy market. This move is the first step in integrating BlueSky with Smith & Nephew and creates a firm base for our long term position in this market. It also improves our ability to meet our customers' needs for NPWT products. We are working closely with the employees at BlueSky Medical to ensure a smooth transition." About us Smith & Nephew is a global medical technology business, specialising in Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company has over 8,800 employees and operates in 31 countries around the world generating annual sales of $2.8 billion. Forward-Looking Statements This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward- looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors. All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based. DATASOURCE: Smith & Nephew plc CONTACT: Sidonie Myers, of Smith & Nephew Advanced Wound Management, +44-1482-673246

Copyright